Fulvic Acid for Anti-Inflammatory

Research suggests that fulvic acid possesses meaningful anti-inflammatory properties across a range of laboratory, animal, and some human-adjacent contexts, with studies pointing to its ability to suppress key inflammatory signaling pathways — including p38 MAPK, JNK, and NF-κB — and reduce pro-inflammatory molecules involved in conditions such as atopic dermatitis, psoriasis, diabetic wound healing, and liver injury. The available evidence base consists predominantly of in vitro cell studies and animal experiments, with reviews of shilajit (a fulvic acid-rich substance) incorporating limited human data suggesting broader immune-modulating and antioxidant effects; no large-scale randomized controlled trials isolating fulvic acid's anti-inflammatory effects in humans were identified among the reviewed literature. Studies indicate that fulvic acid's structural chemical features — including quinones, phenols, and carboxylic acid groups — are likely responsible for these biological activities, and several studies explored fulvic acid in combination with other compounds, making it difficult to attribute observed effects to fulvic acid alone. Reviewers across multiple papers consistently noted that variability in fulvic acid composition, a lack of standardized extraction methods, and the scarcity of well-controlled human trials remain significant limitations that prevent firm clinical conclusions from being drawn at this time.